The high trader consensus on "No" for a new COVID variant of concern before 2027 reflects sustained low risk from current SARS-CoV-2 evolution. As of mid-2026, neither WHO nor ECDC lists any variants meeting VOC criteria, with circulation limited to Omicron sublineages such as XFG and BA.3.2 under monitoring or interest status. BA.3.2 shows notable spike mutations and some immune escape signals but remains at low overall prevalence without driving increased severity or healthcare strain. Updated 2026-2027 vaccines target dominant strains like XFG, while multimodal surveillance including wastewater tracking shows no rapid shifts warranting escalation. This steady landscape, absent major changes in transmissibility or virulence, underpins the market's strong lean against a new designation in the short timeframe ahead.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоДа
$243,750 Объем
$243,750 Объем
Да
$243,750 Объем
$243,750 Объем
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Открытие рынка: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...The high trader consensus on "No" for a new COVID variant of concern before 2027 reflects sustained low risk from current SARS-CoV-2 evolution. As of mid-2026, neither WHO nor ECDC lists any variants meeting VOC criteria, with circulation limited to Omicron sublineages such as XFG and BA.3.2 under monitoring or interest status. BA.3.2 shows notable spike mutations and some immune escape signals but remains at low overall prevalence without driving increased severity or healthcare strain. Updated 2026-2027 vaccines target dominant strains like XFG, while multimodal surveillance including wastewater tracking shows no rapid shifts warranting escalation. This steady landscape, absent major changes in transmissibility or virulence, underpins the market's strong lean against a new designation in the short timeframe ahead.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы